ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,091 | -5.9% | 23,100 | +0.9% | 0.00% | -25.0% |
| Q2 2023 | $4,349 | -41.0% | 22,900 | -37.8% | 0.00% | -33.3% |
| Q1 2023 | $7,371 | -40.0% | 36,800 | -28.8% | 0.01% | -53.8% |
| Q4 2022 | $12,286 | -99.7% | 51,700 | +165.1% | 0.01% | +225.0% |
| Q3 2022 | $3,903,000 | +33.2% | 19,500 | -3.0% | 0.00% | +33.3% |
| Q2 2022 | $2,931,000 | -42.6% | 20,100 | -35.8% | 0.00% | -40.0% |
| Q1 2022 | $5,110,000 | -19.0% | 31,300 | -15.9% | 0.01% | -16.7% |
| Q4 2021 | $6,308,000 | +44.6% | 37,200 | +44.7% | 0.01% | +50.0% |
| Q3 2021 | $4,362,000 | +0.1% | 25,700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,356,000 | +757.5% | 25,700 | +71288.9% | 0.00% | +300.0% |
| Q1 2021 | $508,000 | -82.5% | 36 | -83.9% | 0.00% | -75.0% |
| Q4 2020 | $2,911,000 | -41.2% | 224 | -34.1% | 0.00% | -42.9% |
| Q3 2020 | $4,950,000 | +88.9% | 340 | +92.1% | 0.01% | +75.0% |
| Q2 2020 | $2,621,000 | -57.3% | 177 | -68.6% | 0.00% | -63.6% |
| Q1 2020 | $6,139,000 | +10.4% | 564 | +16.8% | 0.01% | -8.3% |
| Q4 2019 | $5,562,000 | +34.3% | 483 | -6.2% | 0.01% | 0.0% |
| Q3 2019 | $4,141,000 | +106.1% | 515 | +85.9% | 0.01% | +140.0% |
| Q2 2019 | $2,009,000 | -2.7% | 277 | +25.3% | 0.01% | -16.7% |
| Q1 2019 | $2,065,000 | -3.3% | 221 | -24.6% | 0.01% | 0.0% |
| Q4 2018 | $2,136,000 | -60.4% | 293 | -52.4% | 0.01% | -64.7% |
| Q3 2018 | $5,391,000 | +159.4% | 616 | +191.9% | 0.02% | +112.5% |
| Q2 2018 | $2,078,000 | +398.3% | 211 | +31.1% | 0.01% | -55.6% |
| Q1 2018 | $417,000 | -35.9% | 161 | -42.9% | 0.02% | -35.7% |
| Q4 2017 | $651,000 | -62.0% | 282 | -55.4% | 0.03% | -60.0% |
| Q3 2017 | $1,714,000 | +447.6% | 632 | +89.2% | 0.07% | +400.0% |
| Q2 2017 | $313,000 | +421.7% | 334 | +288.4% | 0.01% | +366.7% |
| Q1 2017 | $60,000 | +114.3% | 86 | -62.3% | 0.00% | +50.0% |
| Q4 2016 | $28,000 | -33.3% | 228 | +46.2% | 0.00% | -33.3% |
| Q3 2016 | $42,000 | +27.3% | 156 | -3.7% | 0.00% | +50.0% |
| Q2 2016 | $33,000 | +106.2% | 162 | +189.3% | 0.00% | +100.0% |
| Q1 2016 | $16,000 | -65.2% | 56 | -70.4% | 0.00% | -75.0% |
| Q4 2015 | $46,000 | +100.0% | 189 | +7.4% | 0.00% | +100.0% |
| Q3 2015 | $23,000 | +228.6% | 176 | +2414.3% | 0.00% | +100.0% |
| Q2 2015 | $7,000 | -53.3% | 7 | -77.4% | 0.00% | -50.0% |
| Q1 2015 | $15,000 | -53.1% | 31 | +29.2% | 0.00% | -50.0% |
| Q4 2014 | $32,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,500 | $1,177,000 | 0.01% |
| Timber Hill LLC | 7,700 | $725,000 | 0.00% |
| SIMPLEX TRADING, LLC | 189 | $46,000 | 0.00% |
| Citadel Advisors | 10,500 | $988,000 | 0.00% |